BDBM765933 (1R,4R)-4-((6- (2,6-dichloro-3- ((5-chloro-2- methoxypyridine)- 3- sulfonamido)phenyl) quinazolin-2- yl)amino)-N-(2- methoxyethyl)cyclo- hexane-1-::US20250263400, Compound 21

SMILES COCCNC(=O)[C@H]1CC[C@H](Nc2ncc3cc(-c4c(Cl)ccc(NS(=O)(=O)c5cc(Cl)cnc5OC)c4Cl)ccc3n2)CC1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 765933   

TargeteIF-2-alpha kinase GCN2(Human)
Alesta Therapeutics

US Patent
LigandPNGBDBM765933((1R,4R)-4-((6- (2,6-dichloro-3- ((5-chloro-2- meth...)
Affinity DataIC50: 31.9nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent